Impact of functionality and grading on survival in pancreatic neuroendocrine tumor patients receiving peptide receptor radionuclide therapy

BackgroundPeptide receptor radionuclide therapy (PRRT) is a well-established treatment option for neuroendocrine tumors (NET), yet randomized controlled trials have not provided data on its impact on overall survival. The real-world efficacy of PRRT and its association with tumor functionality and g...

Full description

Saved in:
Bibliographic Details
Main Authors: Annie Mathew, David Kersting, Wolfgang P. Fendler, Johanna Braegelmann, Dagmar Fuhrer, Harald Lahner
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2025.1526470/full
Tags: Add Tag
No Tags, Be the first to tag this record!